Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Allergan, Inc.    AGN   US0184901025


SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on ALLERGAN, INC.
4d ago ALLERGAN : Patent Issued for Hypotensive Lipid and Timolol Compositions and Meth..
4d ago ALLERGAN : Patent Issued for Instrument and Method for Diagnosing Dry Eye in a P..
4d ago ALLERGAN : COTCHETT, PITRE & McCARTHY, LLP : Files Class Action Lawsuit on Behal..
4d ago ALLERGAN : Deadline in Lawsuit for Certain Sellers of Allergan, Inc. (AGN) Share..
4d ago ALLERGAN : BOTTINI & BOTTINI, INC. Files Class Action Lawsuit On Behalf Of Perso..
4d ago ALLERGAN : Pharma Equities Technical Analysis -- GlaxoSmithKline, Bristol-Myers ..
5d agoDJU.S. HOT STOCKS : Hot Stocks to Watch
5d agoDJActavis CEO to Remain After Allergan Merger
5d ago ALLERGAN : Arbor Pharmaceuticals Updates on Wilshire Lastacaft Patent Challenge
6d agoDJBrent Saunders faces challenge of running combined Actavis-Allergan
6d ago ALLERGAN : Assigned Patent
12/11 ALLERGAN : Valeant To Abandon Growth-by-Acquisitions Strategy For Time Being To ..
12/11 ALLERGAN : "Injection Device with Stress Protection" in Patent Application Appro..
12/11 ALLERGAN : Patent Application Titled "Mechanical Syringe Accessory" Published On..
12/10 ALLERGAN : Patent Issued for Hypotensive Lipid-Containing Biodegradable Intraocu..
12/10 ALLERGAN : Researchers Submit Patent Application, "Syringe Extrusion Accessory",..
12/09 Exclusive - Valeant to drop deal-making in near term to cut debt, boost stock
12/08 ALLERGAN : Assigned Patent
12/06 ALLERGAN : New Jersey firm wins Botox maker for $66B
12/05DJActivist Fund ValueAct Capital to Seek Up to $1.5 Billion From Investors -- U..
12/03 ALLERGAN : Patent Issued for Extended Release Biodegradable Ocular Implants
12/01 ALLERGAN : Other Events (form 8-K)
11/29 ALLERGAN : Purchase by Actavis Would Pressure Ratings (Fitch)
11/29 ALLERGAN : Fitch Affirms Actavis at 'BBB-' on Allergan Acquisition Announcement;..
11/27 ALLERGAN : Local boy has suddenly become global player
11/26 ALLERGAN : Patent Issued for Anatomical Recognition and Dimensional Analysis of ..
11/26 ALLERGAN : Patent Issued for Slotted Syringe
11/26 ALLERGAN : Actavis Plans To Reduce Workforce
11/26 WILLIAM ACKMAN : Ackman's Pershing Square sees big payoff from Allergan deal
11/26 Ackman's Pershing Square sees big payoff from Allergan deal
11/25DJCEOS' TEST : Contending With Activist Investors -2-
11/25DJCEOS' TEST : Contending With Activist Investors
11/25 ALLERGAN : Assigned Patent
11/24DJSalix Plans to Boost Size of Board
11/24 ALLERGAN : Investors Who Sold Allergan (AGN) Shares Between April 1, 2014 and Ap..
11/24 ALLERGAN : A much needed facelift for pharmaceuticals industry
11/24 ALLERGAN : Investor Notice: Those Who SOLD NYSE:AGN Shares Between Feb. and Apri..
11/21 ALLERGAN : SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of ..
11/21 ALLERGAN : $66B Actavis-Allergan deal, Cantel Medical leadership appointment & m..
11/21 Valeant slashes stake in Allergan after losing bid
11/21 Global M&A lending hits post-crisis high
11/21 Global M&A deals cross $3 trillion for first time since 2007
11/21DJU.S. Stock Futures Rally on China, Draghi
11/20 Valeant slashes stake in Allergan after losing bid
11/20 Valeant Pharma says may buy back up to $2 billion worth of securities
11/20DJValeant Sets $2 Billion Buyback Plan After Losing Allergan
11/20 MEGA MERGERS : Wall Street sees $100bn deals
11/20 ALLERGAN : Combining the New ThermiRF® with Juvederm Voluma® Provides Exceptiona..
11/19 ALLERGAN : Patent Issued for Implantable Injection Port
11/19 ALLERGAN : Patent Application Titled "Alpha Adrenergic Agonists for the Treatmen..
11/19 ALLERGAN : FDA Approves New Styles of Allergan's NATRELLE® 410 Highly Cohesive A..
11/19DJFor Allergan Suitors, Unorthodox Alliance Proved Unwieldy
11/19 ALLERGAN : AGN SHAREHOLDER ALERT: Levi & Korsinsky, LLP Launches Investigation o..
11/19 ALLERGAN : Sadove Cosmetic Surgery Offers Newly Approved Allergan Breast Implant..
11/19 ALLERGAN : to Sell for $66B in Biggest M&A Deal of 2014
11/18 PERSHING : Bill Ackman Guesses He'll Just Take Actavis' $2.6 Billion And Go Away..
11/18DJGoldman Hits Mother Lode on Deals
11/18DJAckman Drops Push for Allergan Holder Meeting--2nd Update
11/18DJWILLIAM ACKMAN : Ackman Drops Push for Allergan Holder Meeting--Update
11/18 ALLERGAN : Entry into a Material Definitive Agreement, Other Events, Financial S..
11/18 WILLIAM ACKMAN : Ackman supports Allergan's $66 billion sale to Actavis
11/18 ALLERGAN : Actavis agrees to buy Botox-maker Allergan for $66bn
11/18 Ackman supports Allergan's $66 billion sale to Actavis
11/18 ALLERGAN : AGN INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of ..
11/18 ALLERGAN : Face saver: Botox firm plumps for Actavis tie-up
11/18DJActavis Outlines Allergan Breakup Fee, Board Appointments
11/18 ALLERGAN : Actavis to Buy Botox-Maker Allergan for $66 Billion
11/18 ALLERGAN : Generic drugs firm Actavis agrees to buy Allergan for $66 bn
11/18 ALLERGAN : accepts $66bn Actavis takeover bid as Valeant walks
11/18 ALLERGAN, INC. : ex-dividend day
11/17DJDeal Boom Feeds on Surging Stocks
11/17DJActavis To Buy Allergan In $66 Billion Deal -- 5th Update
11/17 ALLERGAN : Face saver Botox firm plumps for Actavis tie-up
11/17DJMARKET SNAPSHOT : S&P 500 Registers 42nd Record Close In Skittish Market
1  2  3  4  5  6  7  8  9  10Next
Duration : Period :
Allergan, Inc. Technical Analysis Chart | AGN | US0184901025 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes